Clinical trials: Anxiety Disorder Social
Social Anxiety Disorder
Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia
This study will assess the effectiveness of D-cycloserine combined with cognitive-behavior therapy in treating people with social anxiety disorder.
- Trial name
- NCT00515879
- Testing
- D-cycloserine, Cognitive behavioral therapy (CBT)
- Where
- United States
- Volunteers
- 169 people
- Sponsor
- Boston University Charles River Campus
Social Anxiety Disorder (SAD)
Nefazodone in the Treatment of Social Phobia
The purpose of this study is to determine the effectiveness of nefazadone in patients with social anxiety disorder (SAD).
- Trial name
- NCT00231348
- Testing
- Nefazodone
- Where
- United States
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Emory University
Diagnosis, Psychiatric
Testing the Right Question Project (RQP) Health Education Strategy in a Mental Health Setting
The purpose of this pilot project is to test the effectiveness of three 20 minute health education modules on patient empowerment, patient activation and retention in care.
- Trial name
- RQP (NCT00134615)
- Testing
- RQP patient health education module
- Where
- 2 sites in United States
- Volunteers
- 231 people
- Sponsor
- Massachusetts General Hospital
Obsessive-Compulsive Disorder (OCD)
Impact of EsTOCma on OCD Family Members
The goal of this clinical trial is to test the acceptability, feasibility, and effectiveness of esTOCma in families and relatives of individuals with obsessive-compulsive disorder (OCD).
- Trial name
- esTOCma family (NCT06616350)
- Testing
- esTOCma: an app to fight stigma associated with OCD
- Where
- Spain
- Volunteers
- 211 people
- Sponsor
- University of Valencia
Stress, Psychological
Reward Under Stress: Effects of a Multidimensional Stress Prevention Program in University Students
The purpose of this study is to investigate the effects of a multidimensional stress prevention program on psychological and physiological indicators among university students.
- Trial name
- NCT03861013
- Testing
- Multidimensional stress prevention program (GeDStress)
- Where
- Switzerland
- Volunteers
- 64 people, healthy volunteers welcome
- Sponsor
- Chantal Martin Soelch
Phobia, Social
Gaze Contingent Feedback in Social Anxiety Disorder
The purpose of this study is to determine whether giving gaze-contingent feedback is an effective attention modification procedure, helping in the treatment of social anxiety disorder (SAD)
- Trial name
- NCT02590770
- Testing
- attention modification
- Where
- Israel
- Volunteers
- 40 people
- Sponsor
- Tel Aviv University
Social Anxiety Disorder
Computer-Based Treatment for Social Anxiety Disorder
The present study is an open trial that seeks to examine the feasibility, acceptability, mechanism, and efficacy of a recently developed computer-based therapy in individuals with social anxiety disorder (SAD)
- Trial name
- NCT03415022
- Testing
- computer-based treatment
- Where
- United States
- Volunteers
- 41 people
- Sponsor
- New York State Psychiatric Institute
Phobic Disorders, Social Phobia
Treatment of Social Phobia
Social phobia is a very common and debilitating disorder, with public speaking anxiety being the most common fear. Psychologists have found that treating patients for their fear of public speaking, through cognitive-behavioral…
- Conditions
- Phobic Disorders, Social Phobia, Public Speaking Anxiety
- Trial name
- NCT00000370
- Testing
- Cognitive behavior therapy, Performance-based exposure therapy, Psychosocial intervention
- Where
- United States
- Sponsor
- Boston University Charles River Campus
Anxiety Disorders
Technology and Early Anxiety Treatment
The goal of the study is to evaluate the efficacy of an Internet-delivered format of an evidence-based CBT treatment for early social anxiety disorder (Coaching Approach behavior and Leading by Modeling, or the CALM Program) in…
- Trial name
- NCT03255122
- Testing
- I-CALM, Delayed I-CALM
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- Florida International University
Obsessive-Compulsive Disorder, Post Traumatic Stress Disorder
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
Anxiety-, obsessive-compulsive and trauma- and stressor-related disorders reflect a significant public health problem. This study is designed to evaluate the predictive power of a novel biomarker based on a CO2 challenge, thus…
- Conditions
- Obsessive-Compulsive Disorder, Post Traumatic Stress Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder
- Trial name
- NCT05467683
- Testing
- Exposure-Based Therapy
- Where
- 2 sites in United States
- Volunteers
- 600 people
- Sponsor
- Jasper A. Smits
Social Anxiety Disorder
Internet-delivered CBT vs Internet-delivered Support and Counseling for Youth With Social Anxiety Disorder - An RCT
Social anxiety disorder among youth is highly prevalent and causes significant impairment in the lives of the affected. In spite of cognitive behavior therapy (CBT) being an effective treatment, research suggests that many young…
- Trial name
- SOFT RCT (NCT03247075)
- Testing
- Cognitive Behavior Therapy, Support and Counseling
- Where
- Sweden
- Volunteers
- 103 people
- Sponsor
- Karolinska Institutet
Selective Mutism, Social Anxiety
Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine
The Department of Counseling, Educational Psychology, and Special Education and the Department of Psychiatry at Michigan State University have coordinated efforts to provide a diagnostic and treatment investigation for children…
- Trial name
- NCT05378711
- Testing
- Fluoxetine
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- Michigan State University
Major Depressive Disorder, Dysthymic Disorder
Quetiapine in Co-Morbid Depressive and Anxiety Disorders
This multi-centred study will be conducted at three centres. The design will be a randomized, placebo-controlled, parallel-group one.
- Conditions
- Major Depressive Disorder, Dysthymic Disorder, Anxiety Disorders, Generalized Anxiety Disorder
- Trial name
- NCT00688818
- Testing
- Quetiapine
- Where
- 4 sites in Canada
- Volunteers
- 108 people
- Sponsor
- Centre for Addiction and Mental Health
Anxiety Disorder of Childhood, Fear
Addressing Anxiety in 2-3-Year-Olds: A Pilot Intervention Study
The purpose of this study is to test the feasibility and efficacy of intervening with 2-year-old children with elevated temperamental Fear and/or Shyness or 3-year-old children with elevated anxiety and their parents, using a…
- Conditions
- Anxiety Disorder of Childhood, Fear, Shyness
- Trial name
- NCT04039243
- Testing
- Being Brave, Parent Education
- Where
- United States
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- Massachusetts General Hospital
COVID-19 Pandemic Psychological Impact, Stress
COVID Feel Good-An Easy Self-Help Virtual Reality Protocol to Overcome the Psychological Burden of Coronavirus
This pragmatic trial aims to evaluate whether a weekly self-help virtual reality protocol can help overcome the psychological burden of the COVID-19 pandemic.
- Conditions
- COVID-19 Pandemic Psychological Impact, Stress, Anxiety Disorders, Depression
- Trial name
- NCT06850376
- Testing
- COVID Feel Good VR Self-Help Protocol, Waiting Period
- Where
- Italy
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- Istituto Auxologico Italiano
Phobia, Social
Dysfunctional Attention Processes in Fear of Blushing: Specificity and Changeability
Blushing is associated with a heightened self-focused attention. In our study we are interested if this self-focused attention can be shown experimentally and if it can be changed by therapy and training.
- Trial name
- NCT00751465
- Testing
- Task Concentration Training, Standard CBT
- Where
- Germany
- Volunteers
- 82 people, healthy volunteers welcome
- Sponsor
- Technische Universität Dresden
Pediatric ALL
Motivational Interviewing in Adolescents With Epilepsy
Epilepsy is the most common serious neurodevelopmental disorder of childhood characterized by recurrent seizures, affecting approximately 0.9% of children and adolescents worldwide.
- Trial name
- NCT06412692
- Testing
- The Motivational Interviewing Technique
- Where
- Turkey (Türkiye)
- Volunteers
- 72 people, healthy volunteers welcome
- Sponsor
- Izmir Katip Celebi University
Cardiac Arrhythmia, Ventricular Fibrillation
Emotional Regulation in Patients With Implanted Automatic Defibrillator
The general objective of the study was to evaluate the impact of two emotional regulation programs, one standardized and face-to-face (MBSR: Mindfulness Based Stress Reduction) and, another, implemented through a mobile phone…
- Conditions
- Cardiac Arrhythmia, Ventricular Fibrillation, Ventricular Tachycardia
- Trial name
- NCT04235881
- Testing
- Mindfulness-based stress reduction program, App REM volver a casa
- Where
- Spain
- Volunteers
- 96 people
- Sponsor
- Instituto de Investigación Hospital Universitario La Paz
Generalized Anxiety Disorder, Social Anxiety Disorder
Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study
This proposed study aims to evaluate the efficacy of daily Cannabidiol (CBD) Oil Capsules in treating symptoms of DSM-5 anxiety disorders, using a two-arm, 8-week randomized, placebo-controlled trial in adults aged 21-65 years.
- Conditions
- Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder, Agoraphobia
- Trial name
- NCT03549819
- Testing
- Cannabidiol (CBD) Oil Capsules, Sunflower Lecithin Oil in Capsule
- Where
- Canada
- Volunteers
- 50 people
- Sponsor
- McMaster University
Anxiety Disorders, Social Phobia
Cerebellar Neuromodulation to Enhance Fear Extinction and Predict Response to Exposure Therapy
Emerging neuroimaging studies have shown that the cerebellum contributes to different aspects of timing, prediction, learning, and extinction of conditioned responses to aversive stimuli, factors that may be relevant to the…
- Trial name
- NCT03275337
- Testing
- Transcranial Direct Current Stimulation
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Laureate Institute for Brain Research, Inc.